Lidogel™ Lidocaine HCI 2.8% Gel

Lidogel by

Drug Labeling and Warnings

Lidogel by is a Otc medication manufactured, distributed, or labeled by PureTek Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

LIDOGEL- lidocaine hci gel 
PureTek Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Lidogel™

Lidocaine HCI 2.8% Gel

Active ingredient

Lidocaine HCI 2.8%

Purpose

Topical analgesic

Uses

  • for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts,
    scrapes, insect bites, and minor skin irritat ion.

Warnings

For external use only

When using this product

  • Avoid contact with the eyes.

Stop use and ask a doctor if

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

Do not use in large quantities, particularly over raw surfaces or blistered areas.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Directions

  • Adults and children 2 years and older- Apply to affected area not more than 3 to 4 times daily
  • Children under 2 years- Consult a doctor

Use under the direction of a medical practitioner

How Supplied:

Lidogel ™ Pain Relieving Gel is supplied in a 3.5 oz (100 g) tube (NDC: 59088-452-07)

Other information

  • Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Avoid excessive heat.
  • Do not use if package is damaged.

Keep this and all medication out of reach of children

Inactive ingredients:

Aloe Barbadensis (Aloe Vera) Leaf Juice, Citric Acid, Hydroxyethylcellulose, Methylparaben, PEG-4, Propylene Glycol, Propylparaben, Purified Water

Questions or comments?

For questions or information call toll-free: 877-921-7873

Lidogel™

Manufactured in the USA by:
PureTek Corporation
San Fernando, CA 91340

Label

LIDOGEL 
lidocaine hci gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 59088-452
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS28 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLYETHYLENE GLYCOL 200 (UNII: R95B8J264J)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 59088-452-07100 g in 1 TUBE; Type 0: Not a Combination Product07/08/202107/08/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34807/08/202107/08/2021
Labeler - PureTek Corporation (785961046)

Revised: 7/2021
 

Trademark Results [Lidogel]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LIDOGEL
LIDOGEL
85455516 not registered Dead/Abandoned
Gensco Laboratories, LLC
2011-10-25
LIDOGEL
LIDOGEL
85455493 not registered Dead/Abandoned
Gensco Laboratories, LLC
2011-10-25
LIDOGEL
LIDOGEL
77071025 not registered Dead/Abandoned
Nickell, Robert P
2006-12-24

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.